
    
      The study will be a double blind randomised controlled trial. There will be two study groups
      and one control group.

      The first study group will be the pregnant women at risk of late preterm birth that will
      receive antenatal corticosteroids in the form of intramuscular dexamethasone sodium
      phosphate.

      The second study group will be the pregnant women at risk of late preterm birth that will
      receive antenatal corticosteroids in the form of intramuscular betamethasone sodium
      phosphate.

      The control group will be pregnant women at risk of late preterm birth that will be given
      intramuscular water for injection.
    
  